Monday, November 17, 2008

Innocoll Receives Fast Track Designation for Gentamicin Surgical Implant

Innocoll, Inc., a privately-held biopharmaceutical company, announced that the FDA has designated Gentamicin SURGICAL Implant as a Fast Track development program.

the details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)